UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dasatinib (BMS-354825) pharmacokinetics correlate with pSRC pharmacodynamics in phase I studies of patients with cancer (CA180002, CA180003)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3046-3046

2006

Volltextzugriff (PDF)

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology

Journal of clinical oncology, 2018-08, Vol.36 (22), p.2326-2347

2018

Volltextzugriff (PDF)

Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline

Journal of clinical oncology, 2019-09, Vol.37 (25), p.2270-2290

2019

Volltextzugriff (PDF)

Epidemiologic Methods to Advance Our Understanding of Ovarian Cancer Risk

Journal of clinical oncology, 2024-08, Vol.42 (22), p.2619-2621

2024

Volltextzugriff (PDF)

Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report

Journal of clinical oncology, 2022-03, Vol.40 (9), p.945-955

2022

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3784-3796

2010

Volltextzugriff (PDF)

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1553-1561

2012

Volltextzugriff (PDF)

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

Journal of clinical oncology, 2019-02, Vol.37 (5), p.423-438

2019

Volltextzugriff (PDF)

Adjuvant Endocrine Therapy for Women With Hormone Receptor―Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

Journal of clinical oncology, 2014-07, Vol.32 (21), p.2255-2269

2014

Volltextzugriff (PDF)

Unresolved Grief in a National Sample of Bereaved Parents: Impaired Mental and Physical Health 4 to 9 Years Later

Journal of clinical oncology, 2008-12, Vol.26 (36), p.5870-5876

2008

Volltextzugriff (PDF)

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1689-1701

2016

Volltextzugriff (PDF)

Accuracy of oncologists’ life-expectancy estimates provided to their advanced cancer patients: Correlates and outcomes

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.10032-10032

2016

Volltextzugriff (PDF)

A cost-effectiveness analysis assessing systemic treatments in metastatic castration-sensitive prostate cancer (mCSPC) by volume of disease

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.93-93

2024

Volltextzugriff (PDF)

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women

Journal of clinical oncology, 2021-11, Vol.39 (31), p.3430-3440

2021

Volltextzugriff (PDF)

Whole transcriptome analysis of tumors with discordant oncotype and MammaPrint results in the FLEX trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.556-556

2022

Volltextzugriff (PDF)

Clinical implications for patients with discordant oncotype and MammaPrint results

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.560-560

2022

Volltextzugriff (PDF)

Pediatric EBV-negative monomorphic post–solid organ transplant lymphoproliferative disorders [EBV(-)M-PTLD]: Characteristics, treatment, and outcome from 11 pediatric academic centers

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10012-10012

2022

Volltextzugriff (PDF)

An AI-derived digital pathology-based biomarker to predict the benefit of androgen deprivation therapy in localized prostate cancer with validation in NRG/RTOG 9408

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.223-223

2022

Volltextzugriff (PDF)

Post-discharge transitions of care for hospitalized patients with advanced cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6504-6504

2017

Volltextzugriff (PDF)

A phase 1a / 1b first-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS2612-TPS2612

2018

Volltextzugriff (PDF)

Prophylactic Urokinase in the Management of Long-Term Venous Access Devices in Children: A Children's Oncology Group Study

Journal of clinical oncology, 2004-07, Vol.22 (13), p.2718-2723

2004

Volltextzugriff (PDF)

Clinical and demographic variables of young adult (YA) patients referred to inpatient supportive care

Journal of clinical oncology, 2018-12, Vol.36 (34_suppl), p.168-168

2018

Volltextzugriff (PDF)

Contemporary national trends of prostate cancer screening among privately insured patients in the United States

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5065-5065

2015

Volltextzugriff (PDF)

Code status transitions from full code to do-not-resuscitate (DNR) among hospitalized patients with advanced cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6592-6592

2017

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Humans
(12)
Life Sciences & Biomedicine
(12)
Oncology
(12)
Science & Technology
(12)
Female
(10)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Tumors
(5)
Breast Neoplasms - Drug Therapy
(4)
Adolescent
(3)
Adult
(3)
Asco Special
(3)
Chemotherapy, Adjuvant
(3)
Male
(3)
Neoplasms - Drug Therapy
(3)
Randomized Controlled Trials As Topic
(3)
Aged
(2)
Aged, 80 And Over
(2)
Antineoplastic Agents - Administration & Dosage
(2)
Antineoplastic Agents, Hormonal - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dasatinib (BMS-354825) pharmacokinetics correlate with pSRC pharmacodynamics in phase I studies of patients with cancer (CA180002, CA180003)

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology

Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline

Epidemiologic Methods to Advance Our Understanding of Ovarian Cancer Risk

Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

Adjuvant Endocrine Therapy for Women With Hormone Receptor―Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

Unresolved Grief in a National Sample of Bereaved Parents: Impaired Mental and Physical Health 4 to 9 Years Later

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression

Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia

Accuracy of oncologists’ life-expectancy estimates provided to their advanced cancer patients: Correlates and outcomes

A cost-effectiveness analysis assessing systemic treatments in metastatic castration-sensitive prostate cancer (mCSPC) by volume of disease

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women

Whole transcriptome analysis of tumors with discordant oncotype and MammaPrint results in the FLEX trial

Clinical implications for patients with discordant oncotype and MammaPrint results

Pediatric EBV-negative monomorphic post–solid organ transplant lymphoproliferative disorders [EBV(-)M-PTLD]: Characteristics, treatment, and outcome from 11 pediatric academic centers

An AI-derived digital pathology-based biomarker to predict the benefit of androgen deprivation therapy in localized prostate cancer with validation in NRG/RTOG 9408

Post-discharge transitions of care for hospitalized patients with advanced cancer

A phase 1a / 1b first-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors

Prophylactic Urokinase in the Management of Long-Term Venous Access Devices in Children: A Children's Oncology Group Study

Clinical and demographic variables of young adult (YA) patients referred to inpatient supportive care

Contemporary national trends of prostate cancer screening among privately insured patients in the United States

Code status transitions from full code to do-not-resuscitate (DNR) among hospitalized patients with advanced cancer

Aktive Filter

Suchergebnisse filtern